Mobile

Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-003658-47

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To assess the percentage of responders in both treatment groups, Milnacipran or Venlafaxine administered up to 200 mg/day in flexible doses, during a treatment period of 8 weeks including up-titration, in out patients with Major Depressive Disorder.

Critère d'inclusion

  • Major Depressive Disorder

Liens